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MicroRNAs (miRNAs) are ,22-nt regulatory RNAs expressed
by all multicellular eukaryotes [1]. Humans encode .700
miRNAs and similar numbers are likely to exist in other
mammalian species. Almost all cellular miRNAs are initially
transcribed by RNA polymerase II (Pol II) as part of a long,
capped, polyadenylated primary miRNA (pri-miRNA) precursor.
The miRNA forms part of one arm of an RNA stem-loop that
consists of an ,32-bp imperfect stem flanked by unstructured
RNA sequences. This stem-loop is recognized by the nuclear
RNase III enzyme Drosha, which cleaves the stem to liberate an
,60-nt pre-miRNA hairpin. The pre-miRNA is then transported
to the cytoplasm where it is cleaved by a second RNase III
enzyme, called Dicer, which removes the terminal loop to generate
the miRNA duplex intermediate. One strand of this duplex is
incorporated into the RNA-induced silencing complex (RISC),
where it acts as a guide RNA to direct RISC to complementary
mRNA species [1]. Depending on the level of complementarity,
RISC can either cleave bound mRNAs and/or inhibit their
translation. Inhibition of mRNA translation generally requires full
complementarity of the mRNA to nucleotides 2 through 7 or 8
from the miRNA 59 end—the miRNA seed region. The primary,
and possibly sole, function of mammalian miRNAs is therefore to
act as specific post-transcriptional inhibitors of mRNA function.
Do All Viruses Encode miRNAs?
Because miRNAs are potent regulators of gene expression that
are both small and non-antigenic, they would seem ideal tools to
alter the cellular environment in ways that favor virus replication.
While numerous virally encoded miRNAs have, in fact, been
described for members of the herpesvirus family, few other viral
miRNAs have been identified (Table 1). In general, we can divide
mammalian viruses into three categories, i.e., the herpesviruses,
which encode multiple viral miRNAs; other nuclear DNA viruses,
which may encode one or two miRNAs; and the RNA viruses and
cytoplasmic DNA viruses, which appear to lack any miRNAs [1].
While this generalization is clearly subject to revision as more
viruses are analyzed, viruses that currently appear to lack any
miRNAs include retroviruses (e.g., human immunodeficiency virus
type 1 [HIV-1]), flaviviruses (e.g., yellow fever virus), hepatitis C
virus (HCV), and papillomavirus [2,3]. In addition, deep sequenc-
ing of small RNAs isolated from cells infected with cowpox virus or
influenza A virus has also failed to identify any virally encoded
miRNAs (J. L. Umbach and B. R. Cullen, unpublished data).
Although the reason for this pattern of viral miRNA expression
remains unknown, one can speculate that viruses that replicate in
the cytoplasm (e.g., flaviviruses, HCV, and cowpox) might lack
miRNAs because they never encounter the nuclear enzyme
Drosha. On the other hand, nuclear RNA viruses (e.g., influenza
and HIV-1) may avoid encoding miRNAs because excision of a
genomically encoded pre-miRNA would induce the cleavage and
degradation of the viral RNA genome. Finally, one can speculate
that viruses that establish long-term, latent infections (e.g.,
herpesviruses) would derive more benefit from the use of non-
antigenic miRNAs to inhibit cellular antiviral responses than
would viruses that have short lytic replication cycles.
What Do Viral miRNAs Do?
Only a small number of mRNA targets of viral miRNAs have
been defined, so a complete answer to this question is currently not
possible. However, the emerging picture [4] suggests that viral
miRNAs may serve two major functions. On the one hand, several
viral miRNAs have been shown to inhibit the expression of cellular
factors that play a role in cellular innate or adaptive antiviral
immune responses. Examples of the inhibition of host cell factors
involved in mediating immune responses include the natural killer
cell ligand MICB, which is downregulated by miRNAs encoded by
human cytomegalovirus (hCMV), Kaposi’s sarcoma-associated
herpesvirus (KSHV), and Epstein-Barr virus (EBV) [5], and the
pro-apoptotic protein PUMA, which is downregulated by an EBV
miRNA [6]. The potential selective advantage conferred on a virus
by this downregulation is obvious. Secondly, several viral miRNAs
downregulate the expression of viral proteins, including key viral
immediate-early or early regulatory proteins. For example, herpes
simplex virus 1 (HSV-1) downregulates the immediate-early
transactivators ICP0 and ICP4 in latently infected cells by using
viral miRNAs that are expressed at high levels during latency, but
not during productive viral replication. This action is thought to
stabilize the latent state [7]. Conversely, several polyomaviruses
downregulate the expression of the viral T antigens, key early
transcription factors, at late stages in the viral replication cycle
[8,9,10].Ithasbeenproposedthat this reduces the killingofinfected
cells by cytotoxic T lymphocytes specific for T antigen epitopes [8].
Although it is therefore widely believed that viral miRNAs play
an important role in the replication and pathogenesis of the viruses
that encode them, little evidence in support of this hypothesis
currently exists. Indeed, a mutant polyomavirus lacking the only
polyomavirus-encoded miRNA replicated indistinguishably from
wild-type in infected mice [9]. Whether herpesviruses, which
encode more viral miRNAs, do depend on these small RNAs will
no doubt soon be revealed.
Are Viral miRNAs Conserved between Related
Viral Species?
If viral miRNAs do play an important role in viral replication
and pathogenesis, then they should be under purifying selection.
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isolates reveals that the miRNAs encoded by KSHV are, in general,
highly conserved, although isolates bearing mutations that block
production of individual KSHV miRNAs have been described [11].
A similar high level of conservation also appears to be characteristic
of miRNAs encoded by other human herpesviruses, including EBV
and hCMV.
In contrast, a comparison between distinct but related
herpesvirus species reveals far less evidence of miRNA sequence
conservation, although the genomic localization of virally encoded
miRNAs is often conserved. In the case of HSV-1, which encodes
eight known viral miRNAs, and the related but distinct HSV-2,
which encodes at least six miRNAs, four miRNAs are partially
conserved in terms of sequence, and fully conserved in terms
of genomic localization [12]. Similarly, 22 of the 25 miRNAs
encoded by EBV are at least partially conserved in the related
c-herpesvirus rhesus lymphocryptovirus (rLCV), which encodes a
remarkable 33 miRNAs [13]. In contrast, none of the 12 miRNAs
expressed by KSHV are conserved in the somewhat more distantly
related rhesus rhadinovirus (RRV), although all virally encoded
miRNAs are found in a single cluster located adjacent to the viral
ORF71 gene in both virus species [2,13,14]. It is therefore likely
that viral miRNAs evolve through a combination of sequence
evolution of pre-existing miRNA stem-loops combined with an
occasional stem-loop duplication event [13]. As miRNAs are short,
readily mutable sequences, any degree of evolutionary conserva-
tion implies that miRNAs can confer a significant selective
advantage. Presumably, sequence conservation of viral miRNAs
also implies the existence of cellular, rather than viral, mRNA
targets, as the latter might be expected to rapidly co-evolve with
viral miRNAs.
Do Viruses Regulate miRNA Transcription,
Processing, or Function?
Viral infection represents a cataclysmic event in the life of a cell
that generally results in dramatic changes in cellular mRNA
expression. These may include the induction of cellular factors that
have the potential to resist or promote viral replication. As cellular
miRNAs are also transcribed by Pol II, it is expected that viral
infection would also affect their pattern of expression. The
question then is whether these changes are evolutionarily selected
to favor or inhibit virus replication. At present, there is no
evidence indicating that viruses modify the cellular environment to
selectively favor the processing and expression of viral miRNAs,
although viral miRNAs may be expressed at such high levels that
they have the potential to competitively inhibit cellular miRNA
function.
While it has been proposed that HIV-1 infection induces the
expression of specific cellular miRNAs [15], the best-characterized
example of a virus inducing cellular miRNAs that may favor virus
infection occurs in the case of EBV, which induces the expression
of several cellular miRNAs, including miR-155, in infected B cells
[16]. In contrast, while KSHV does not induce miR-155
expression upon infection of B cells, it does encode a viral miRNA
that functions as an ortholog of miR-155 [17,18]. As miR-155 can
promote the oncogenic transformation of B cells when overex-
pressed in vivo, it is likely that miR-155 induction by EBV, or
expression of a miR-155 mimic by KSHV, plays a role not only in
promoting the establishment of EBV or KSHV latency, but also in
viral transformation of B cells [16,17,18].
While viruses may therefore enhance cellular miRNA expres-
sion, the more commonly observed effect is inhibition [15,19].
Moreover, there have been several reports demonstrating that
cellular miRNAs can inhibit virus replication and/or that artificial
inhibition of miRNA production or function can enhance virus
replication in culture [15,20,21,22,23]. Many viruses globally
repress Pol II transcription in infected cells, and this would also
repress miRNA biogenesis. In addition, adenoviruses produce the
viral VA1 non-coding RNA, which acts as a potent inhibitor of
both pre-miRNA nuclear export and pre-miRNA processing by
Dicer [24]. The HIV-1 Tat protein has also been proposed to
inhibit miRNA function, although this appears to require very
high levels of Tat expression [19].
Can Viruses Use Cellular miRNAs to Promote Their
Replication?
At least one clear-cut example of a cellular miRNA that
facilitates virus replication is known, i.e., activation of HCV
replication by the liver-specific miRNA miR-122 [25]. The HCV
RNA genome contains two miR-122 binding sites in its 59
untranslated region that are required for activation of viral
genomic RNA replication, although the underlying mechanism
remains obscure. At present, this result remains unique to HCV;
i.e., no other RNA virus has been shown to rely upon direct
binding of a cellular miRNA to its RNA genome for any aspect of
its replication cycle.
An interesting and largely unresolved aspect of the replication
cycle of RNA viruses is that their RNA genome must serve several
essential yet mutually exclusive roles. Thus, the HCV genome is
not only the mRNA that encodes all the viral proteins but also the
substrate for the viral RNA-dependent RNA polymerase and the
genomic RNA that is packaged into progeny virions. It is
interesting to speculate that cellular miRNAs could play a role
in retargeting viral RNAs away from translation and towards one
of the latter two fates. Of note, RISC is believed to direct bound
mRNAs into cytoplasmic processing bodies (P bodies), where they
may be translationally repressed and/or degraded, yet emerging
evidence suggests that P bodies can also function as sites of viral
RNA synthesis [26]. Currently, it remains unclear how viruses
deal with the potentially inhibitory effect of the large numbers of
Table 1. MicroRNAs Encoded by Mammalian Viruses.
Virus Family Virus Species Host Known miRNAs
a-herpesviruses HSV-1 Human 8
HSV-2 Human 6
b-herpesviruses hCMV Human 11
mCMV Murine 18
c-herpesviruses EBV Human 25
rLCV Simian 33
KSHV Human 12
RRV Simian 15
MHV68 Murine 9
Polyomaviruses polyoma Murine 1
SV40 Simian 1
JCV Human 1
BKV Human 1
Adenovirus hAV Human 2
This table lists the number of currently known pre-miRNA stem-loops encoded
by each virus listed. BKV, BK virus; hAV, human adenovirus; JCV, JC virus; mCMV,
murine cytomegalovirus; MHV68, mouse c-herpesvirus 68.
doi:10.1371/journal.ppat.1000787.t001
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RNA genomes and/or mRNAs. Have they simply evolved to
inhibit miRNA function and/or minimize the number of
functional binding sites for the miRNA species that are expressed
in infected cells, or have they instead evolved ways to take
advantage of these miRNAs? This issue is one that deserves
significant attention, as it may suggest novel methods to selectively
perturb the replication of pathogenic viruses in vivo.
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